Qualifying Notice for Gavreto (English, HTML)

View metadata and access the original English HTML file: Qualifying Notice for Gavreto.

Format

HTML

Access

file-only

Publisher-reported update

2023-11-01

This Notice of Compliance with Conditions Qualifying Notice (NOC/c-QN), issued in accordance with the Health Canada Guidance Document: Notice of Compliance with Conditions (NOC/c), is to advise you that information submitted in support of the New Drug Submission for Gavreto (pralsetinib), Control Number 243731, for the indication of the treatment of adult patients with rearranged during transfection (RET) fusion-positive locally advanced unresectable or metastatic non-small cell lung cancer (NSCLC).

Access original file